Multimodal machine learning models are combining non-traditional physiological data streams, including sleep sensors, wrist movement, and ECGs, to forecast chronic diseases and mortality years before clinical diagnosis.

AI developers are shifting from specialized imaging to opportunistic screening, extracting systemic disease markers from routine, low-cost clinical data like basic ECGs, retinal photos, and wearable pulse signals.

As clinical AI transitions to active decision-making, a wave of validation failures and self-overestimation is forcing healthcare buyers to inherit the entire burden of real-world model safety.

Clinical AI models are increasingly being outperformed by, or failing to improve upon, traditional statistical methods and established clinical formulas in critical predictive tasks.